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Ultrasensitive retrovirus detection by a reverse transcriptase
assay based on product enhancement
Abstract
Reverse transcriptase (RT) is an indispensable component of infectious retroviruses. We have developed
an ultrasensitive RT test in which RNA of bacteriophage MS2 serves as the template for RT-mediated
cDNA synthesis. A fragment of the cDNA is selectively amplified by polymerase chain reaction and the
amplification product is analyzed by Southern blot hybridization or enzyme immunoassay. The
procedure was 10(6) to 10(7) times more sensitive than a conventional RT test and detected as little as
10(-9) unit of murine leukemia virus RT, which corresponded to 2.1 x 10(2) molecules, a number
present in 3-11 virions. As a screening assay for filterable particle-associated RT, it was positive with
supernatants from cell cultures producing human immunodeficiency virus (HIV) type 1 or human T-cell
leukemia virus (HTLV) type 1 or 2, but was negative with nonproducer cultures. It was positive with
plasma samples from all tested individuals infected with HIV-1, HIV-2, or HTLV-1 and sera from cats
infected with feline leukemia virus or feline immunodeficiency virus. Control samples from blood
donors or uninfected cats were negative. Density banding experiments with culture supernatants showed
that the RT activity was associated with virus particles. The assay should detect all
replication-competent retroviruses or similar agents. It may be used as a screening assay for such agents,
for quantitation of the viral load, drug susceptibility testing of RT, and control of virus inactivation in
biological products.
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ABSTRACT Reverse transcriptase (RT) is an indispens-
able component of infectious retroviruses. We have developed
an ultrasensitive RT test in which RNA of bacteriophage MS2
serves as the template for RT-mediated cDNA synthesis. A
fragment of the cDNA is selectively amplified by polymerase
chain reaction and the amplication product is analyzed by
Southern blot hybridization or enzyme immunoassay. The
procedure was 10'6 to 107 times more sensitive than a conven-
tional RT test and detected as little as 10-9 unit of murine
leukemia virus RT, which corresponded to 2.1 X 102 molecules,
a number present in 3-11 virions. As a screening assay for
filterable particle-associated RT, it was positive with superna-
tants from cell cultures producing human immunodeficiency
virus (11V) type 1 or human T-cell leukemia virus (fITLV)
type 1 or 2, but was negative with nonproducer cultures. It was
positive with plasma samples from all tested individuals in-
fected with HIV-1, HIV-2, or HTLV-1 and sera from cats
infected with feline leukemia virus or feline immunodeficiency
virus. Control samples from blood donors or uninfected cats
were negative. Density banding experiments with culture su-
pernatants showed that the RT activity was associated with
virus particles. The assay should detect all replication-
competent retroviruses or similar agents. It may be used as a
screening assay for such agents, for quantitation of the viral
load, drug susceptibility testing of RT, and control of virus
inactivation in biological products.
Infectious retroviruses are important causative agents of
human and animal disease. They all possess a characteristic
enzyme, reverse transcriptase (RT), and can thus be detected
by assays for this activity (1, 2). However, the current tests
are insensitive when compared with virus-specific methods.
Detection of human immunodeficiency virus type 1 (HIV-1)
by RT assay, for example, is 100 times less sensitive than by
antigen (Ag) assay (3). Polymerase chain reaction (PCR) is
again orders of magnitude more sensitive (4).
The narrow detection range of sequence-based tests such
as PCR is, however, a disadvantage when detection of
retroviruses in general is the aim. Attempts to detect unchar-
acterized retroviruses by the use of PCR with primers from
conserved genomic regions have been met with some success
but lack sensitivity and, therefore, require prior isolation and
multiplication of the virus in a suitable host cell line usually
difficult to find (5). Here, we report the development of an
ultrasensitive RT assay capable of detecting retroviruses at a
sensitivity hitherto reserved to virus-specific sequence am-
plification.
tained from R. C. Gallo (National Institutes of Health, Be-
thesda, MD). HTLV-IIIB was also produced in C81-66-45
(hence called C81-66-45/HIV-1). The HTLV-1 producer
MT-2 was from I. Miyoshi (Kochi Medical School, Kochi,
Japan), the cloned HTLV-2 producer 76D9 was from J.
Jendis (our laboratory), and the uninfected monocytoid cell
line RC2A was from P. Stoeckbauer (Center for Hematology
and Blood Transfusion, Prague). All lines were kept in RPMI
1640 medium plus 10% fetal bovine serum, 100 international
units of penicillin G per ml, 100 jig of streptomycin per ml,
2.5 Mg of amphotericin B per ml (all from GIBCO), and 5%
interleukin 2 (IL-2) (Cellular Products).
Cultures offresh human blood cells were set up from either
donor buffy coats obtained from the local Red Cross trans-
fusion center or from known cases of HIV-1 infection.
Cultures were kept in RPMI 1640 medium plus 20% fetal
bovine serum and antibiotics (basic medium) under one ofthe
following modalities. (i) Stimulated whole blood (WHB)
culture: The washed cell pellet of 1 ml of EDTA blood was
cultured in basic medium plus 10%o IL-2, 2 ug of phytohem-
agglutinin-P (PHA) per ml (GIBCO), 1% (vol/vol) pokeweed
mitogen (PWM) extract (GIBCO), and 10 pg of lipopolysac-
charide (LPS) per ml (Sigma). (ii) Stimulated WHB coculture:
The washed WHB pellet was cocultured with 2 x 106
Ficoll-purified normal peripheral blood mononuclear cells
(PBMCs) pretreated with PHA for 3 days and the cells were
kept in the medium used for stimulated WHB cultures. (iii)
WHB coculture: The washed WHB pellet was cocultured
with 2 x 106 PHA-pretreated normal PBMCs and the cells
were kept in basic medium plus 10% IL-2. (iv) PBMC culture:
106 PBMCs were cultured for 3 days in basic medium plus
PHA. (v) PBMC coculture: 106 PBMCs were cocultured with
2 x 106 PHA-pretreated normal PBMCs and kept for 14 days
in basic medium plus IL-2 or PHA or PWM at the above
concentrations.
Plasma and Sera. EDTA plasma samples from patients
infected with HIV-1, HIV-2, or HTLV-1 were stored at
-70° C. Sera, stored at -20° C, from cats infected with feline
leukemia virus (FeLV) or feline immunodeficiency virus
(FIV) or from cats bred under specific pathogen-free condi-
tions (SPF cats) were from H. Lutz (University Veterinary
Hospital, Zurich).
Sample Pretreatment. One milliliter of plasma, serum, or
culture supernatant was centrifuged at 16,000 x g for 10 mi
and filtered through 0.2 ,um (Minisart NML, Sartorius).
These measures greatly improved specificity of the product-
MATERIALS AND METHODS
Cell Cultures. Uninfected cell line H9, HIV-1 producer
H9/HTLV-IIIB, and the human T-cell leukemia virus type 1
(HTLV-1)-transformed nonproducer C81-66-45 were ob-
Abbreviations: RT, reverse transcriptase; PERT assay, product-
enhanced reverse transcriptase assay; HIV, human immunodefi-
ciency virus; HTLV, human T-cell leukemia virus; Ag, antigen; IL-2,
interleukin 2; WHB, whole blood; PHA, phytohemagglutinin-P;
PWM, pokeweed mitogen; LPS, lipopolysaccharide; PBMC, periph-
eral blood mononuclear cell; FeLV, feline leukemia virus; FIV,
feline immunodeficiency virus; SPF, specific pathogen-free; BSA,
bovine serum albumin; MuLV, murine leukemia virus.
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enhanced RT assay (PERT assay), while not significantly
affecting sensitivity. The volume was adjusted to 2.25 ml by
phosphate-buffered saline (PBS, GIBCO) and particulate
material was pelleted at 70,000 X gavg for 90 min. The pellet
was resuspended in 30 Al of buffer A consisting of 50 mM
KCI, 25 mM Tris HCl (pH 7.5), 5 mM dithiothreitol, 0.25 mM
EDTA, 0.025% Triton X-100, and 50% glycerol (6).
PERT Assay. Reverse transcription. Genomic RNA of
bacteriophage MS2 (Boehringer Mannheim) was used for
template. A synthetic oligonucleotide, RT-1 [5'-d(CATAG-
GTCAAACCTCCTAGGAATG)-3'], served as primer. Prim-
er/template was freshly prepared for each experiment by
mixing, per reaction, 0.3 pug of MS2 RNA (0.28 pmol) with 72
ng of primer RT-1 (9 pmol) in H20, heating at 950C for 5 min,
annealing at 37TC for 30 min, and chilling the mixture on ice
for 5 min. Per reaction, primer/template in 1.4 /l of H20 was
added to 23.6 ul of buffer containing the other ingredients,
resulting in a reaction mixture of 56 mM Tris HCl (pH 8.3),
56 mM KCl, 9 mM MgCl2, 11.2 mM dithiothreitol, 1 unit of
RNase inhibitor (RNasin) per ,u (Promega), 0.13 pg ofbovine
serum albumin (BSA) per ul (Boehringer Mannheim), 0.4%
Triton X-100, and 1 mM (each) dNTP. The reaction mixture
was overlaid with 50 /4 of mineral oil, and 3 Al of pretreatedsample or an alternative source of RT in buffer A was added.
The reaction was carried out at 37° C for 5 hr and the mixture
was heated at 95° C for 7 min to inactivate the RNase
inhibitor.
Product amplification. Amplification of the MS2 cDNA
was carried out by PCR with primer RT-2 [5'-d(TCCTGCT-
CAACTTCCTGTCGAG)-3'] and primer RT-1. To the RT
reaction mixture, 75 ul of a PCR reaction mixture containing
14 pmol of RT-1, 25 pmol of RT-2, 8 ng of RNase A (United
States Biochemical), 2.5 units of Taq DNA polymerase
(Amplitaq, Perkin-Elmer) in 37.5 mM KCl, 10 mM Tris HCl
(pH 8.3), and 0.01% gelatin were added. After 30 min of
incubation at 37° C, for template degradation by RNase A, 25
cycles consisting of 94° C/30 sec of denaturation, 55° C/100
sec of annealing, and 72° C/110 sec of synthesis were carried
out on a Techne Laboratories (Princeton) PHC-2 thermal
block. The amplification produced a 112-bp-long DNA frag-
ment that represented positions 21-132 of the 5' end of the
MS2-RNA (GenBank accession no. J02467).
Conventional RT Assay. The assay was done as described
(7). Five micrograms of poly(rA)-oligo(dT) (Pharmacia) was
used for primer/template. Virus from pretreated samples was
lysed by adding half the volume of a solution containing 1.5
M KCl and 0.9% Triton X-100. Ten microliters ofthis mixture
was assayed; the reaction volume was 100 Al. The final buffer
conditions were as those for the RT reaction of the PERT
assay and the reaction was carried out at 37° C for 22 hr. The
enzymatic activity was assessed by measuring the incorpo-
rated tritiated thymidine monophosphate.
RNA PCR. For cDNA synthesis, 3 ,ul ofvirus was lysed and
reverse-transcribed in 25 /41 ofa reaction mixture containing 25
pmol of sequence-specific primer HT-X2 [5'-d(TGAGC-
CGATAACGCGTCCATCGAT)-3'], 50 mM Tris-HCl (pH
8.3), 50mM KCl, 8 mM MgCl2, 10mM dithiothreitol, 1 unit of
RNase inhibitor per Il4, 0.12 pg of BSA per ,u, 0.4% Triton
X-100, 1 mM (each) dNTP, and 50 units ofrecombinant murine
leukemia virus (MuLV) RT (GIBCO/BRL). The mixture was
incubated at 37° C for 90 min. The whole reaction mixture was
then added to 75 Al of a PCR mixture containing 25 pmol of
primer HT-X1 [5'-d(TTCGGATACCCATGCTACGT-
GTTTG)-3'] and 2.5 units of TaqDNA polymerase in 37.5mM
KCl, 10 mM TrisHCl (pH 8.3), and 0.01% gelatin. The
samples were subjected to 30 cycles ofamplification, using the
same cycle profile as for the PERT assay.
Detection of Amplified DNA Products. Southern blot. Ten
microliters of amplified MS2 DNA was separated on a 1.5%
agarose gel and blotted to nylon membrane (Hybond-N plus,
Amersham) by alkaline transfer, according to the manufac-
turer's protocols. Probe RT-3 [5'-d(TTAATGTCTTTAGC-
GAGACGC)-3'], labeled at the 5' end with 32p, was used for
hybridization (8). Membranes were exposed to Fuji RX x-ray
films. For quantitation, bands were cut from the membrane
and assayed in a scintillation counter.
Nonisotopic detection of amplified DNA products. Am-
plified HTLV-1 DNA was analyzed by an ELISA-based
detection system (9) modified by the use of other oligonu-
cleotide probes. The HTLV-1 DNA product was hybridized
with probes HT-X4-DIG [5'-digoxigenin-d(TGGCCACCT-
GTCCAGAGCATCA)-3'] and HT-X6-Bio [5'-biotin-
d(TGTGTACAGGGCGACTGGTG)-3']. The hybrids were
bound to avidin-coated microtiter plates. Unbound material
was washed off and bound digoxigenin was detected with a
horseradish peroxidase-labeled anti-digoxigenin antibody
and 3,3',5,5'-tetramethylbenzidine as substrate in a 5-min
incubation.
For analysis of MS2 DNA products, hybridization was
carried out with probes RT-3-Bio [5'-biotin-d(TTAAT-
GTCTTTAGCGAGACGC)-3'] and RT-5-DIG [5'-digoxige-
nin-d(ATGGCTATCGCTGTAGGTAGC)-3']. After binding
of the hybrids to avidin-coated wells, bound digoxigenin was
detected with alkaline phosphatase-labeled anti-digoxigenin
Fab fragments (Boehringer Mannheim) at a dilution of 1:625.
The enzymatic reaction was carried out with p-nitrophenyl
phosphate (Pierce) in diethanolamine buffer at 370C for 20
min. The system is at least as sensitive as Southern blot.
Sucrose Gradient Density Banding. Culture supernatants
were pretreated as above, but the pellets were resuspended
in 0.5 ml of TN buffer (50 mM Tris, pH 7.5/50 mM NaCl)
instead of buffer A. The samples were layered on 16-ml
continuous 10-60%o (wt/wt) sucrose in TN buffer gradients
and centrifuged in a Kontron (Zurich) TST 28.17 rotor at
70,000 x g for 16 hr. Fractions of 0.5 ml were collected from
the bottom and their densities were determined in a Zeiss
refractometer. For analysis by PERT assay or RNA PCR, the
fractions were diluted to 2.0 ml with PBS and virus was
pelleted at 4° C/70,000 x g.,g for 90 min. The pelleted material
was resuspended in 30 ,l4 of buffer A.
RESULTS
The PERT assay uses PCR for the selective enhancement of
the MS2 cDNA synthesized by RT activity. The procedure
described in Materials and Methods represents the results of
many experiments performed to define conditions under
which the assay would work at the desired high sensitivity
and specificity.
In this procedure it was critical to guarantee that the
reagents used did not contain amplifiable DNA, that such
DNA was not introduced with the sample, and that no cDNA
was produced from the RNA template by endogenous RT
activity associated with the assay reagents themselves. Ge-
nomic RNA of MS2 was chosen for template since the
replication of this phage does not involve a DNA intermedi-
ate (10). A systematic contamination of the template by
amplifiable DNA or inadvertent introduction of such DNA by
a sample was thus impossible. As a heteropolymer the MS2
RNA had the further advantage of being much less efficiently
used by eukaryotic DNA polymerases than the synthetic
homopolymeric templates usually employed for RT tests (7).
To prevent degradation by RNases present in the test sample,
the template was stabilized by placental RNase inhibitor.
In experiments shown in Fig. 1, the assay reagents were
systematically examined for contaminating amplifiable DNA
and for endogenous RT activity, using ELISA-based product
analysis. In Fig. 1A, the reverse transcription step of the
procedure was omitted and the assay reagents were directly
submitted to PCR. In the absence of MS2 RNA, the reagents
Medical Sciences: Pyra et al.
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FIG. 1. Identification of sources of endogenous signal generation
in the PERT assay. (A) Absence of contamination with DNA
homologous to MS2 RNA and presence of endogenous RT activity
in different batches of Taq DNA polymerase. Reagents tested were
directly submitted to amplification by 30 cycles of PCR for MS2
DNA. (B) Demonstration ofendogenous RT activity in two different
preparations ofRNase inhibitor, tested in the absence (a) or presence
(i) of a low amount of MuLV RT.
used in the amplification step, including three different
batches of Taq DNA polymerase (Taq 1-3), yielded each an
OD of 0.032, which was equal to the substrate background.
This indicated that the step 2 reagents were free of contam-
inating amplifiable DNA. The same batches of Taq DNA
polymerase, when used in combination with a constant
amount of MS2 RNA, yielded positive signals of different
intensities. This suggested the presence ofRT activity in Taq
DNA polymerase preparations, as reported by others (11).t
This interpretation was corroborated by the demonstration
that degradation of the MS2 RNA by 8 ng of RNase A prior
to amplification reduced the signal to the background level.
The following controls showed that the signal reduction
exerted by RNase A was not due to inhibition of amplifica-
tion: direct amplification of MS2 cDNA by Taq 3 yielded the
same signal, independent of whether or not RNase A was
added. This result also excluded a contamination of MS2
RNA or RNase A by MS2 cDNA. Amplification ofRT buffer,
buffer A, or Triton X-100 with still another batch of Taq DNA
polymerase (Taq 4) showed in addition that the reagents used
for reverse transcription were free of contaminating DNA.
Using the complete PERT assay procedure, the reagents of
the reverse transcription step were tested for product gen-
eration in the absence or presence of a low activity of MuLV
RT (Fig. 1B). In the absence of RNase inhibitor, the assay
showed the expected results: absence of signal in the absence
ofRT and good signal with RT, respectively. However, with
RNase inhibitor 1, purified from human placenta, a strong
signal was produced and the added RT activity could no
longer be distinguished from the background. Less endoge-
nous activity was found with the recombinant RiNase inhib-
itor 2 (the human placenta protein expressed in E. coli). No
product was generated when the template was digested by
RNase A prior to incubation with RNase inhibitor 1, indi-
cating that neither RNase A nor the RNase inhibitor was
contaminated by amplifiable DNA.
In conclusion, these experiments showed that the assay
reagents were free of amplifiable DNA, but that the RNase
inhibitor and the Taq DNA polymerase both contained RT
activity, which raised the background and, consequently, the
detection limit of the assay. Therefore, all batches of RNase
inhibitor were screened for RT activity and only those with
low activity were used. In addition, the template was rou-
tinely digested by RNase A prior to amplification. These
measures guaranteed a background sufficiently low to permit
detection of very low RT activities.
The sensitivity of this system was assessed in a model
experiment in which serial dilutions of recombinant MuLV
RT were tested in parallel by conventional RT test and PERT
assay (Fig. 2A). The detection limit of the RT test was
between 10-2 and 10-3 unit. By contrast, the PERT assay
clearly detected 10-9 unit, while 10-10 unit was within
background. Thus, the detection limit of the PERT assay was
106 to 107 times lower than that of the conventional test.
The dilution experiment also showed that below 10-7 unit
the signal obtained with the PERT assay was proportional to
the RT activity and that thus, in this range, the test could be
used for quantitation. The detection limit and quantitative
range both depended on the number of amplification cycles
(Fig. 2B): 10 cycles rendered RT detection 100 times more
sensitive than the conventional procedure. An increase to 25
cycles resulted in an additional 105-fold increase in sensitiv-
ity. With >25 cycles, the increasing background precluded a
further gain in sensitivity (not shown).
The capability of the assay to identify retroviruses present
at numbers too low to be detected by conventional RT assay
was assessed in a sucrose gradient density banding experi-
ment performed with supernatants from HTLV-i-producing
MT-2 cells and a PBMC coculture control originating from
two normal blood donors, respectively. The MT-2 superna-
tant was diluted 1:1000 into the PBMC supernatant prior to
sample pretreatment and banding, while the PBMC super-
natant was used undiluted. Gradient fractions were analyzed
by PERT assay (Fig. 3A). No PERT activity was detected in
any of the fractions of the PBMC coculture. In MT-2 super-
natant, the activity banded at a single peak at a density of 1.14
g/ml. RNA PCR confirmed that this peak corresponded to
HTLV-1 particles (Fig. 3B). Conventional RT assay per-
formed with fractions of the diluted MT-2 supernatant indi-
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FIG. 2. Detection of RT activity by PERT assay. Southern blot
was used for product analysis. (A) Comparison of RT activity by
PERT assay with 25 cycles of amplification (*) and a conventional
RT test (o) in serial dilutions of recombinant MuLV RT. Horizontal
broken lines indicate backgrounds. (B) Detection level and range of
quantitative detection of the PERT assay in dependence of the
number of amplification cycles: C, 10; *, 15; o, 20; m, 25 cycles.
tActivity was particularly high with Taq 1. Boiling partially removed
activity indicating contamination by at least one heat-sensitive
Escherichia coli polymerase. The remaining activity was, though,
heat-resistant and thus exerted by Taq DNA polymerase itself.
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FIG. 3. Sucrose density banding of supernatants from HTLV-1-
producing MT-2 cells and from a coculture of normal PBMCs and
analysis by PERT assay and RNA PCR. (A) PERT analysis. The axis
on the left indicates cpm of 32P-labeled probe RT-3 bound to
amplified MS2 DNA after Southern blot hybridization. The axis on
the right indicates density of the gradient (x). Undiluted super-
natant ofthe PBMC coculture; *, supernatant ofMT-2 diluted 1:1000
in the supernatant of the PBMC coculture. (B) Analysis of HTLV-1
RNA (o) by RNA PCR.
cated absence of activity, while positive and negative con-
trols showed the expected results (data not shown).
Based on these results, a procedure for the detection of
filterable particle-associated RT was developed, to be used as
a screening assay for retroviruses. Sample fluids were pre-
cleared by high-speed centrifugation and filtered. Particulate
material was then pelleted by ultracentrifugation and ana-
lyzed by PERT assay. In Southern blot analysis (Fig. 4A),
strong signals were obtained with supernatants from cell lines
producing HIV-1, HTLV-1, or HTLV-2, while with the
chosen film exposure no signals were detected with undiluted
supernatants from nonproducers C81-66-45 and RC2A. Un-
diluted supernatants from unstimulated PBMC or PHA-
stimulated PBMC cultures were also negative, while the
PBMC coculture of an HIV-1-infected patient was positive.
After longer film exposure, however, faint reactions were
also detected with cultures considered uninfected, in partic-
ular with stimulated or unstimulated PBMC cultures (data not
shown). Distinct signals were found when plasma samples
from patients infected with HIV-1, HIV-2, or HTLV-1 or
serum samples from cats infected with FeLV or FIV were
assayed (Fig. 4B). By contrast, a blood donor plasma and the
serum ofa SPF cat were negative. RNA PCR ofvirus pelleted
from plasma of the HTLV-1-infected patient gave a weak-
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FIG. 5. Ag p24 and RT activity in supernatants of WHB cultures
or cocultures from three individuals infected with HIV-1 (D) and four
HIV-negative controls (r). The cutoff of positivity for the Ag assay
was at an OD of 0.020, which corresponds to about 2 pg/ml (broken
horizontal line). PERT assay was performed with 25 cycles of
amplification and ELISA-based product analysis. Cutoffs of posi-
tivity are shown as horizontal broken lines and the method back-
ground (mean ± 1 SD) is shown as a shaded area.
positive result (not shown), in concordance with the rela-
tively weak signal obtained in the PERT assay. All of five
additional plasma samples from unselected blood donors
were negative by PERT assay while all of five additional
plasma samples from HIV-1-infected patients were strongly
positive (Fig. 4C).
Since cellular DNA polymerases represent a possible
source of false positivity, their interference with the PERT
assay was assessed in cell cultures established from whole
blood of healthy donors. Cultures from HIV-1-infected indi-
viduals were used as positive controls. Fig. 5 shows a
representative experiment in which WHB cells from four
donors and three HIV-1 positives were maintained under the
various culture conditions described in Materials and Meth-
ods, including WHB cocultures (Fig. SA), stimulated WHB
cocultures (Fig. 5B), and stimulated WHB cultures (Fig. SC).
Supernatants were tested weekly for HIV-1 Ag (upper pan-
els) and for RT activity by PERT assay using ELISA-based
product analysis (lower panels). Fig. 5 shows that even under
conditions of harsh stimulation leading to extensive cell
death, as demonstrated microscopically in the case of stim-
ulated WHB cocultures (data not shown), the RT activities in
the blood donor cultures were only minimally (up to four
times) higher than the method background.
C
FIG. 4. Detection of filterable particle-associated RT by PERT assay. Southern blot was used for product analysis. Film exposure was 24
hr for A and B and 4 hr for C. (A) RT activity in cell cultures. Supernatants from C81-66-45, RC2A, MT-2, unstimulated or stimulated PBMCs,
and PBMCs producing HIV-1 were tested undiluted and those from C81-66-45/HIV-1 and 76D9 were at 10-3 and 10-4, respectively. (B) RT
activity in serum or plasma of retrovirus-infected cats or humans (BD, blood donor). (C) Absence of RT activity from all of five additional blood
donor samples and presence in all of five additional unselected samples from HIV-1-infected individuals of different clinical stages.
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Based on these findings, cutoffs of positivity (mean + 5
SD) were calculated and used for interpretation of cultures
from HIV-1 positives. All were, at least initially, PERT-
positive. By contrast, Ag p24 assay completely failed to
detect virus in stimulated WHB cocultures and in two ofthree
stimulated WHB cultures.
Similar results were seen with PBMC cocultures from three
other HIV-1 patients and three other blood donors (data not
shown). Together, these experiments showed that the PERT
assay was definitely more sensitive than the Ag assay and
correctly identified all HIV-infected cultures. On the other
hand, the cocultures from a total of 14 individuals (2 per
coculture) considered uninfected showed very little activity,
even under conditions of extensive cell death and, conse-
quently, the release of cellular polymerases.
DISCUSSION
Association with filterable particle-associated RT activity is
a hallmark of infectious retroviruses and of diagnostic im-
portance. The PERT assay now adds the high sensitivity of
PCR to the broad detection range of the RT assay. The result
is an assay capable of detecting, at unprecedented sensitivity
and specificity, RT and thus a wide variety of human and
animal retroviruses that may have but little sequence homol-
ogy in common (Fig. 4).
The low background (Fig. 1) permitted 25 rounds ofcDNA
amplification resulting in the detection of <10-9 unit of RT
activity (Fig. 2A). Given the specific activity of >40,000
units/mg and the Mr of71,000 ofthe MuLV RT used, the 10-9
unit represents 2.1 x 102 RT molecules, which corresponds
to 3-11 virions based on estimates of20-70 RT molecules per
virion in avian and mammalian type C retroviruses (12-14).
Direct comparative testing of serial dilutions of HIV-1 by
PERT assay and RNA PCR indicated a detection limit of
about 10 virions for both methods (unpublished data).
The high specificity of the PERT assay is documented by
the demonstration that negative controls yielded negative
results (Fig. 4) and control cell supernatants showed minimal
activity even under massive stimulation by alloantigen, PHA,
PWM, and LPS, which resulted in extensive cell death (Fig.
5), and by gradient analysis of MT-2 or PBMC coculture
supernatants showing absence of particle-associated activity
from fractions other than those containing virions (Fig. 3).
Furthermore, testing of culture supernatants with elevated
activity in the conventional RT test confirmed that the PERT
assay is considerably more specific: of 29 samples with RT
activity .20,000 cpm (i.e., 10-15 times the method back-
ground), 27 were negative by PERT assay and the 2 positives
were also positive for HIV-1 Ag (not shown).
The high sensitivity, specificity, and broad range of agents
to which it is sensitive predispose the PERT assay for use as
a universal screening assay for all agents associated with RT
activity. The procedure permits the direct detection of such
agents in primary materials, thereby obviating the need for
virus cultivation. In addition to the known agents, the test
may identify hitherto unrecognized retroviruses. Further
studies will need to show whether other retroelements-e.g.,
hepatitis B virus-can also be detected. The PERT assay may
further be used for quantitation of virus load, for evaluation
of virus inactivation procedures, or to determine the suscep-
tibility of a virus to RT inhibitors.
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